赛诺医疗
(688108)
| 流通市值：40.31亿 | | | 总市值：40.31亿 |
| 流通股本：4.13亿 | | | 总股本：4.13亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 100,849,103.23 | 458,739,271.36 | 318,486,443.24 | 213,692,262.55 |
| 营业收入 | 100,849,103.23 | 458,739,271.36 | 318,486,443.24 | 213,692,262.55 |
| 二、营业总成本 | 106,844,000.33 | 490,838,082.21 | 355,578,619.17 | 238,544,415.05 |
| 营业成本 | 40,680,235.11 | 174,587,205.02 | 123,276,333.08 | 87,193,779.96 |
| 税金及附加 | 1,202,230.15 | 3,645,204.88 | 2,059,947.27 | 1,527,928.92 |
| 销售费用 | 15,103,424.6 | 78,953,775.78 | 55,039,586.14 | 37,006,450.01 |
| 管理费用 | 22,321,712.5 | 89,493,215.42 | 65,686,835.82 | 42,441,456.03 |
| 研发费用 | 26,583,284.27 | 140,557,411.47 | 106,407,498.18 | 68,264,921.24 |
| 财务费用 | 953,113.7 | 3,601,269.64 | 3,108,418.68 | 2,109,878.89 |
| 其中:利息费用 | 1,325,300.18 | 5,612,265.45 | 4,197,871.37 | 2,817,804.57 |
| 其中:利息收入 | 714,748.88 | 2,421,000.73 | 1,681,037.77 | 1,114,478.6 |
| 加:投资收益 | - | 11,194,579.02 | 11,194,579.02 | 11,194,579.02 |
| 资产处置收益 | - | 287,342.75 | - | - |
| 资产减值损失(新) | 3,735,993.18 | -18,054,165.47 | -7,904,949.4 | -3,220,337.35 |
| 信用减值损失(新) | -47,658.14 | 426,622.77 | 113,867.28 | -102,641.31 |
| 其他收益 | 6,567,123.44 | 21,278,567.97 | 16,564,853.19 | 11,676,247.92 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 4,260,561.38 | -16,965,863.81 | -17,123,825.84 | -5,304,304.22 |
| 加:营业外收入 | 69.69 | 617,920.02 | 653,763.92 | 586,507.4 |
| 减:营业外支出 | 13,704.36 | 810,410.9 | 254,128.28 | 17,544.84 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 4,246,926.71 | -17,158,354.69 | -16,724,190.2 | -4,735,341.66 |
| 减:所得税费用 | 1,531,549.45 | -13,268,874.08 | -1,792,789.37 | -4,921,615.22 |
| 六、净利润 | 2,715,377.26 | -3,889,480.61 | -14,931,400.83 | 186,273.56 |
| 持续经营净利润 | 2,715,377.26 | -3,889,480.61 | -14,931,400.83 | 186,273.56 |
| 归属于母公司股东的净利润 | 2,969,330.7 | 1,497,793.42 | -10,915,893.04 | 3,490,568.65 |
| 少数股东损益 | -253,953.44 | -5,387,274.03 | -4,015,507.79 | -3,304,295.09 |
| (一)基本每股收益 | 0.01 | 0 | -0.03 | 0.01 |
| (二)稀释每股收益 | 0.01 | 0 | -0.03 | 0.01 |
| 八、其他综合收益 | 127,504.82 | -1,086,798.73 | -1,557,247.24 | -1,149,046.97 |
| 归属于母公司股东的其他综合收益 | 127,504.82 | -1,086,798.73 | -1,557,247.24 | -1,149,046.97 |
| 九、综合收益总额 | 2,842,882.08 | -4,976,279.34 | -16,488,648.07 | -962,773.41 |
| 归属于母公司股东的综合收益总额 | 3,096,835.52 | 410,994.69 | -12,473,140.28 | 2,341,521.68 |
| 归属于少数股东的综合收益总额 | -253,953.44 | -5,387,274.03 | -4,015,507.79 | -3,304,295.09 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-30 | 2024-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |